Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting

被引:27
|
作者
Rodier, Simon Gabriel [1 ]
Bukur, Marko [1 ]
Moore, Samantha [1 ,2 ]
Frangos, Spiros George [1 ]
Tandon, Manish [1 ]
DiMaggio, Charles Joseph [1 ]
Ayoung-Chee, Patricia [1 ]
Marshall, Gary Thomas [1 ,3 ]
机构
[1] NYU, Bellevue Hosp Ctr, Dept Surg, Sch Med, 462 First Ave, New York, NY 10016 USA
[2] St Johns Univ, Coll Pharm & Hlth Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA
[3] Med City Plano, 4001 W 15th St,Suite 200, Plano, TX 75093 USA
关键词
Trauma; Prophylactic anticoagulation; Weight-based anticoagulation; Anti-factor Xa assay;
D O I
10.1007/s00068-019-01215-0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Venous thromboembolism (VTE) is a common morbidity in trauma patients. Standard VTE chemoprophylaxis is often inadequate. We hypothesized that weight-based dosing would result in appropriate prophylaxis more reliably than fixed dosing. Methods All patients admitted to a Level 1 trauma center over a 6-month period were included unless contra-indications for VTE prophylaxis existed. A prospective adjusted-dosing group was compared to a retrospective uniform-dosing group. The adjusted-dosing approach consisted of initial weight-based dosing of 0.5 mg/kg subcutaneously (subQ) every 12 h (q12h). Peak anti-factor Xa was measured. Patients outside of the prophylactic range had their dose adjusted by +/- 10 mg. The uniform-dosing group received 30 mg subQ q12h, without adjustments. Results Eighty-four patients were included: 44 in the retrospective control cohort and 40 in the prospective experimental cohort. More patients were sub-prophylactically dosed in the uniform-dosing group relative to the adjusted-dosing group (25% vs 5%, p = 0.03). There was no difference in overall prophylactic range targeting, because the supra-prophylactically dosed patients in the adjusted-dosing group eliminated the effect (p = 0.173). However, after a single dose adjustment, zero patients were outside of prophylactic range (25% versus 0%, RR = infinite, p = 0.003). In the uniform-dosing group, anti-Xa level correlated with body surface area (BSA; R-2 = 0.33, p < 0.0001) and weight (R-2 = 0.26, p = 0.0005). Weight-based dosing both pre- and post-readjustment normalized the correlation of anti-Xa with BSA (R-2 = 0.07, p = 0.1) and weight (R-2 = 0.07, p = 0.1). Conclusions Weight-based VTE prophylaxis with anti-Xa-based dose adjustment improves prophylactic range targeting relative to uniform dosing and eliminates variances secondary to BSA and weight in trauma patients.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 2 条
  • [1] Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting
    Simon Gabriel Rodier
    Marko Bukur
    Samantha Moore
    Spiros George Frangos
    Manish Tandon
    Charles Joseph DiMaggio
    Patricia Ayoung-Chee
    Gary Thomas Marshall
    European Journal of Trauma and Emergency Surgery, 2021, 47 : 145 - 151
  • [2] Low molecular weight heparin for venous thromboembolism prophylaxis in general Intensive Care Unit patients: an anti-factor Xa level-based approach
    Zohar, Nitzan
    Ellis, Martin H.
    Dichtwald, Sara
    Meyer, Avraham
    Zohar, Edna
    Ifrach, Nisim
    MINERVA ANESTESIOLOGICA, 2023, 89 (05) : 425 - 433